Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tumor Necrosis Factor-α Inhibitor Use in Psoriasis Patients With a First-degree Relative With Multiple Sclerosis.
Risk Factors for Suicidal Ideation in Patients Feeling Severely Affected by Multiple Sclerosis.
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis.
The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.
Assessing risks of multiple sclerosis therapies.
Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.
ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro.
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a.
Multiple sclerosis: Regenerative therapies for MS-hope on the horizon.
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.
Silent, invisible and unacknowledged: experiences of young caregivers of single parents diagnosed with multiple sclerosis.
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.
Multiple sclerosis: Genotyping study identifies a plethora of new susceptibility variants for multiple sclerosis.
From mishap to model: The origins and utility of experimental autoimmune encephalomyelitis.
Depressive syndromes in neurological disorders.
Biochemical Pharmacology of the Sigma-1 Receptor.
PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: A comparison between [(11)C]CIC and [(11)C]MeDAS.
Variations in predicted risks in personal genome testing for common complex diseases.
Robot Therapy Tipping Point: Caveats for Post hoc Speculation.
Acute Disseminated Encephalomyelitis Without Optic Neuritis Followed by Optic Neuritis in a Child Due to the Sudden Cessation of Steroid Therapy.
Laser speckle imaging to improve clinical outcomes for patients with trigeminal neuralgia undergoing radiofrequency thermocoagulation.
Experimental Autoimmune Encephalomyelitis in Marmosets.
Myelinating Cultures: An In Vitro Tool to Identify Demyelinating and Axopathic Autoantibodies.
Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System.
Pages
« first
‹ previous
…
496
497
498
499
500
501
502
503
504
…
next ›
last »